Historical shareholding details of UBS Asset Mgmt Americas Inc holdings in Allogene Therapeutics Inc (ALLO)

Monthly changes of UBS Asset Mgmt Americas Inc shareholding in Allogene Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Dec 31, 2024 Ubs Asset Mgmt Americas Inc 270,559 0.13%
Sep 30, 2024 Ubs Asset Mgmt Americas Inc 228,806 0.11%
Jun 30, 2024 Ubs Asset Mgmt Americas Inc 266,784 0.13%
Mar 31, 2024 Ubs Asset Mgmt Americas Inc 170,287 0.08%
Dec 31, 2023 Ubs Asset Mgmt Americas Inc 156,709 0.09%
Sep 30, 2023 Ubs Asset Mgmt Americas Inc 156,709 0.09%
Jun 30, 2023 Ubs Asset Mgmt Americas Inc 533,236 0.32%
Mar 31, 2023 Ubs Asset Mgmt Americas Inc 533,236 0.32%
Dec 31, 2022 Ubs Asset Mgmt Americas Inc 0 0.00%

View all ownership details of Allogene Therapeutics Inc